Valeant Organization J. Michael Pearson Chairman & CEO Howard Schiller Chief Financial Officer Rob Chai-Onn General Counsel Ryan Weldon Company Group Chairman Brian Stolz Chief Human Capital Officer & Administration Laizer Kornwasser Company Group Chairman • Tom Appio North Asia • Tanya Carro Corporate Controller • Andrew Howden Australia, Southeast Asia, India, S. Africa • Jerry Janeczko Information Technology • Linda LaGorga Treasurer • Jeremy Lipshy Tax • Andrew Davis Corporate Development • Dennis Asharin Supply Chain & Procurement • Open Customer Service • Jacques Dessureault Canada • Robert Polans Managed Markets • Steve Sembler OraPharma, Neuro & Other • Asha Soto Trade Relations Seana Carson Chief Compliance Officer Dan Wechsler Company Group Chairman Tage Ramakrishna Chief Medical Officer Pavel Mirovsky President & GM EMEA • Dennis Asharin Manufacturing • Marcelo Barboza Brazil & Argentina • Open Sales & Marketing Surgical Equipment • Richard D’Souza R&D, Eye Care • Craig Dashefsky Commercial Ops • Philip Gioia Generics • Joe Gordon Consumer • Calvin Roberts CMO, Eye Care • Javier Rovalo Mexico • Hemanth Varghese Vision Care • Open Sales & Marketing Pharma • Open Sales & Marketing Surgical Lenses • Charles Hahn Professional Relations • Vincent Ippolito Aesthetics • Craig Dashefsky Commercial Operations • Deborah Jorn Marketing, Dermatology • Robert Polans Sales, Dermatology • Tage Ramakrishna R&D, Dermatology Neuro and Other • Preston Romm Obagi • John Connolly Region 2 • Christos Kartalis Region 3 • Open Region 4 • Leszek Wojtowicz Region 1 NOTE - Rod Unsworth, Mike Gowen, and Sue Hall have agreed to stay on for the transition. Laurie Little Investor Relations Exhibit 99.2 |
Bausch Health Companies (BHC) 8-KRegulation FD Disclosure
Filed: 29 Jul 13, 12:00am